Use of immunosuppressive therapy for management of myelodysplastic syndromes: a systematic review and meta-analysis

Immunosuppressive therapy (IST) is one therapy option for treatment of patients with lower-risk myelodysplastic syndromes (MDS). However, the use of several different immunosuppressive regimens, the lack of high-quality studies, and the absence of validated predictive biomarkers pose important chall...

Descripción completa

Detalles Bibliográficos
Autores principales: Stahl, Maximilian, Bewersdorf, Jan Philipp, Giri, Smith, Wang, Rong, Zeidan, Amer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939518/
https://www.ncbi.nlm.nih.gov/pubmed/31004015
http://dx.doi.org/10.3324/haematol.2019.219345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939518/
https://www.ncbi.nlm.nih.gov/pubmed/31004015
http://dx.doi.org/10.3324/haematol.2019.219345

Ejemplares similares